Until researchers can come out with a potent enough antiviral combo to account for the massive numbers of mutations that hepatitis c virus can produce, interferon will remain part of hepatitis C treatments.
One thing that was crystal clear to me was that a private company that had appreciated assets or assets likely to appreciate needed an awful good reason to remain a C corporation.
Choosing March 31, 2009 as a rough bottom, even Citigroup ( C) and Bank of America ( BAC), which remain relative basket cases to this day, would have brought you a roughly 50% gain.